Open AccessTUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
Author(s) -
Romualdo Barroso de Sousa,
Svitlana Tyekucheva,
Pedro Exman,
Renato Umeton,
F. Stephen Hodi,
Eric P. Winer,
Nancy U. Lin,
Sara M. Tolaney
Publication year - 2019
Publication title -
mastology
Language(s) - English
Resource type - Conference proceedings
eISSN - 2594-5408
pISSN - 2594-5394
DOI - 10.29289/259453942019v29s1g04
Subject(s) - triple negative breast cancer , medicine , oncology , cancer research , breast cancer , metastatic breast cancer , cancer , immune checkpoint , triple negative , immunotherapy